DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 210 filers reported holding DEPOMED INC in Q4 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $891,000 | +7.2% | 132,325 | +4.9% | 0.00% | 0.0% |
| Q1 2018 | $831,000 | -15.9% | 126,154 | +3.0% | 0.00% | 0.0% |
| Q4 2017 | $988,000 | +42.4% | 122,517 | +2.2% | 0.00% | 0.0% |
| Q3 2017 | $694,000 | -45.8% | 119,867 | +0.5% | 0.00% | 0.0% |
| Q2 2017 | $1,280,000 | -7.9% | 119,225 | +7.8% | 0.00% | 0.0% |
| Q1 2017 | $1,390,000 | -29.7% | 110,642 | +0.7% | 0.00% | -50.0% |
| Q4 2016 | $1,977,000 | +36.6% | 109,881 | +88.5% | 0.00% | +100.0% |
| Q3 2016 | $1,447,000 | +402.4% | 58,305 | +285.9% | 0.00% | – |
| Q2 2016 | $288,000 | +36.5% | 15,110 | 0.0% | 0.00% | – |
| Q1 2016 | $211,000 | -2.3% | 15,110 | +29.3% | 0.00% | – |
| Q4 2015 | $216,000 | +9.6% | 11,687 | 0.0% | 0.00% | – |
| Q3 2015 | $197,000 | +7.1% | 11,687 | +32.7% | 0.00% | – |
| Q2 2015 | $184,000 | -8.0% | 8,807 | 0.0% | 0.00% | – |
| Q1 2015 | $200,000 | +41.8% | 8,807 | 0.0% | 0.00% | – |
| Q4 2014 | $141,000 | +6.0% | 8,807 | 0.0% | 0.00% | – |
| Q3 2014 | $133,000 | – | 8,807 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DELTEC ASSET MANAGEMENT LLC | 2,252,402 | $31,376,000 | 7.88% |
| Healthcare Value Capital, LLC | 350,000 | $4,876,000 | 7.16% |
| Senvest Management, LLC | 4,977,256 | $69,333,000 | 5.82% |
| Consonance Capital Management LP | 2,756,360 | $38,396,000 | 5.81% |
| Opaleye Management Inc. | 325,000 | $4,527,000 | 2.82% |
| Krensavage Asset Management, LLC | 447,000 | $6,227,000 | 2.23% |
| Healthcare Value Capital, LLC | 100,000 | $1,393,000 | 2.05% |
| Starboard Value LP | 2,950,000 | $41,094,000 | 1.44% |
| HealthInvest Partners AB | 200,000 | $2,786,000 | 1.30% |
| OAK RIDGE INVESTMENTS LLC | 7,206,286 | $100,384,000 | 1.29% |